AIM ImmunoTech Inc. (AIM) Free cash flow 2016–2024
AIM ImmunoTech Inc. (AIM) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$14.9MFY2024 · since FY2016: -$7.5M → -$14.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$14.9M | — |
| FY2022 | -$16.2M | -15.6% |
| FY2021 | -$14.0M | -34.8% |
| FY2020 | -$10.4M | -13.7% |
| FY2019 | -$9.1M | +14.6% |
| FY2018 | -$10.7M | -34.3% |
| FY2017 | -$8.0M | -5.6% |
| FY2016 | -$7.5M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice